The page is the record's research on the issuer — no analyst, no rating, no view. # KIORA PHARMACEUTICALS INC (NASDAQ: KPRX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is KIORA PHARMACEUTICALS INC, listed on NASDAQ under ticker KPRX. Its ISIN is US49721T5074 and its LEI is 549300395G8DB8ZFV365. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States — Delaware. Its segment is not on the record. Its listing status is listed, not halted. ## The disclosure read The record holds 50 filings in the twelve months to 2026-11-08, across 28 filing days. The median gap between filing days is 7 days, against a NASDAQ median of 6.0 days and a 2834 Pharmaceutical Preparations median of 6.0 days. The latest filing is dated 2026-10-29 and is of type corporate_news, 10 days before the record date, against a NASDAQ median latency of 5.0 days and a sector median of 4.0 days. The filings by type are: 18 directors_dealings, 16 regulatory_filing, 6 results, 4 corporate_news, 3 director_change, 2 prospectus, and 1 agm_egm. The NASDAQ median is 52 filings and the sector median is 63.0 filings. ## Auditor The auditor of record is HASKELL & WHITE LLP, located in Irvine, California. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage One research house is named on the issuer's own investor-relations page: Maxim Group. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 10 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001372514.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NASDAQ/KPRX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1372514/000137251426000024/kprx-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://ir.kiorapharma.com/company-information/analyst-coverage (coverage) - https://mcp.us-cm-kg.ai/record/NASDAQ/KPRX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/KPRX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp